Biotechnology

Laurus Labs Limited Q4 FY23 Earnings Conference Call Insights

Laurus Labs Limited Q4 FY23 Earnings Conference Call InsightsLaurus Labs Limited Q4 FY23 Earnings Conference Call Insights

https://youtu.be/5Vtl-XMN8qg Key highlights from Laurus Labs Limited (LAURUSLABS) Q4 FY23 Earnings Concall Management Update: [00:09:24]LAURUSLABS said it invested in expanding…

Laurus Labs Limited Q3 FY23 Earnings Conference Call Insights

Laurus Labs Limited Q3 FY23 Earnings Conference Call InsightsLaurus Labs Limited Q3 FY23 Earnings Conference Call Insights

Key highlights from Laurus Labs Limited (LAURUSLABS) Q3 FY23 Earnings Concall Management Update: [00:03:57] LAURUSLABS said its strong results were…

Syngene International Ltd (SYNGENE) Q3 FY23 Earnings Concall Transcript

Syngene International Ltd (SYNGENE) Q3 FY23 Earnings Concall TranscriptSyngene International Ltd (SYNGENE) Q3 FY23 Earnings Concall Transcript

Syngene International Ltd (NSE: SYNGENE) Q3 FY23 Earnings Concall dated Jan. 24, 2023 Corporate Participants: Avantika Mishra -- Associate - EY Jonathan…

Syngene reported a 5% rise in its net profit for Q3FY23

Syngene reported a 5% rise in its net profit for Q3FY23Syngene reported a 5% rise in its net profit for Q3FY23

Syngene International reported a 5.5% rise in consolidated net profit to INR 109.70 crore in Q3 FY23 as against INR104…

Syngene International Ltd (SYNGENE) Q3 FY23 Earnings Concall Transcript

Syngene International Ltd (SYNGENE) Q3 FY23 Earnings Concall TranscriptSyngene International Ltd (SYNGENE) Q3 FY23 Earnings Concall Transcript

Syngene International Ltd  (NSE: SYNGENE) Q3 FY23 Earnings Concall dated January 24, 2023 Corporate Participants: Avantika Mishra -- Associate - EY Jonathan…

Shares of Biocon research arm soars as it reports 23% rise in its revenue

Shares of Biocon research arm soars as it reports 23% rise in its revenueShares of Biocon research arm soars as it reports 23% rise in its revenue

Syngene International reported a 5.5% rise in consolidated net profit to INR 109.70 crore in Q3 FY23 as against INR104…

Biocon Limited (BIOCON) Q2 FY23 Earnings Concall Transcript

Biocon Limited (BIOCON) Q2 FY23 Earnings Concall TranscriptBiocon Limited (BIOCON) Q2 FY23 Earnings Concall Transcript

Biocon Limited (NSE: BIOCON) Q2 FY23 Earnings Concall dated Nov. 14, 2022 Corporate Participants: Saurabh Paliwal -- Head, Investor Relations…

Dishman Carbogen Amcis Ltd (DCAL) Q2 FY22 Earnings Concall Transcript

Dishman Carbogen Amcis Ltd (DCAL) Q2 FY22 Earnings Concall TranscriptDishman Carbogen Amcis Ltd (DCAL) Q2 FY22 Earnings Concall Transcript

Dishman Carbogen Amcis Ltd (NSE: DCAL) Q2 FY22 Earnings Concall dated Nov. 11, 2022 Corporate Participants: Arpit Vyas -- Global Managing Director…

Laurus Labs Limited Q2 FY23 Earnings Conference Call Insights

Laurus Labs Limited Q2 FY23 Earnings Conference Call InsightsLaurus Labs Limited Q2 FY23 Earnings Conference Call Insights

https://youtu.be/ZaM0EH45MvA Key highlights from Laurus Labs Limited (LAURUSLABS) Q2 FY23 Earnings Concall Management Update: [00:10:45] LAURUSLABS said that on the…

Laurus Labs Limited (LAURUSLABS) Q2 FY23 Earnings Concall Transcript

Laurus Labs Limited (LAURUSLABS) Q2 FY23 Earnings Concall TranscriptLaurus Labs Limited (LAURUSLABS) Q2 FY23 Earnings Concall Transcript

Laurus Labs Limited (NSE:LAURUSLABS) Q2 FY23 Earnings Concall dated Oct. 21, 2022 Corporate Participants: Satyanarayana Chava -- Chief Executive Officer V.V. Ravi Kumar -- Chief Financial…

Laurus Labs Limited Q1 FY23 Earnings Conference Call Insights

https://youtu.be/gMXrmnAGz9Y Key highlights from Laurus Labs Limited (LAURUSLABS) Q1 FY23 Earnings Concall Management Update: LAURUSLABS said it expects the US…

Laurus Labs Limited Q4 FY22 Earnings Conference Call Insights

https://youtu.be/83rl6ffkU9c Key highlights from Laurus Labs Limited (LAURUSLABS) Q4 FY22 Earnings Concall Management Update: LAURUSLABS said that based on its…

Laurus Labs Limited Q3 FY22 Earnings Conference Call Insights

https://www.youtube.com/watch?v=Q_K9qU7RXvI Key highlights from Laurus Labs Limited (LAURUSLABS) Q3 FY22 Earnings Concall Management Update: In 3Q, the company faced some…

Infographic: All you need to know about Dr Reddy’s Labs Q2 performance

Dr. Reddy's Laboratories(NSE:DRREDDY) recently reported its second-quarter 2022 earnings results. The company had a consolidated revenue of ₹5,992 crores with…